A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
PHASE3
A study to evaluate cadonilimab (AK104) + lenvatinib in combination with tr...
This study is a single-arm, multi-center, prospective phase II trial aimed ...
Status
Recruiting
Location
Fujian provincial hospital
Start Date
2024-09-30
Trial ID
NCT06569498
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
PHASE2
This study is an open-label, multicenter, single-arm Phase II clinical stud...